12 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

DIMENSION VISTA C3 AND C4 FLEX REAGENT CARTRIDGE, PROTEIN 1 CALIBRATOR, CONTROL LOW, MEDIUM, HIGH

FDA 510(k)
FDA Class 2 ·Immunology

Henry Schein

FDA UDI
HENRY SCHEIN, INC.·10304040115616·Roth Brackets .018" UR1 12T 5A 0O

DIMENSION HAIC ASSAY, MODEL DF105

FDA 510(k)
FDA Class 2 ·Hematology

PERIPHERAL ARTERIAL TONOMETER-PAT 1000RD DEVICE

FDA 510(k)
FDA Class 2 ·Cardiovascular

UNKNOWN

FDA Adverse Event
WILLIAM COOK EUROPE·Product code DTK·October 27, 2015

EPIC II CRITICAL CARE BED

FDA Adverse Event
Malfunction ·STRYKER MEDICAL-KALAMAZOO·Product code FNL·April 16, 2013

FORMULA TOM CAT CUTTER

FDA Adverse Event
Malfunction ·STRYKER CORP·Product code FZT·April 14, 2011

STRYKER

FDA Adverse Event
Malfunction ·STRYKER·Product code DZH·June 17, 2008

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

CADD¿- Solis Ambulatory Infusion Pump, Model 2111 & 2112, Version 1.0, Version 2.0 and Version 3.0 & Model 2120, Version 1.0. Provide measured drug therapy to patients in hospital or outpatient settings.

FDA Enforcement
Class II ·Terminated·Smiths Medical ASD, Inc.·June 24, 2015

CADD-Solis VIP ambulatory Infusion Pumps, Model 2120 (21-2120, 21-2125, and 21-2127) Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024

Alcon Custom Pak

FDA Enforcement
Class II ·Ongoing·Alcon Research, LTD.·August 23, 2023